A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo

Oncology Letters - Greece
doi 10.3892/ol.2018.9262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells

Biomolecules
BiochemistryMolecular Biology
2019English

A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

A Novel PI3K Inhibitor iMDK Suppresses Non-Small Cell Lung Cancer Cooperatively With a MEK Inhibitor

Experimental Cell Research
Cell Biology
2015English

In Vitro and in Vivo Effects of the Conformationally Restricted Polyamine Analogue CGC-11047 on Small Cell and Non-Small Cell Lung Cancer Cells

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2008English

Recent Advances in Targeted Small-Molecule Inhibitor Therapy for Non-Small-Cell Lung Cancer-An Update

Journal of Clinical Pharmacy and Therapeutics
Pharmacology
2020English

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

Targeted Oncology
Cancer ResearchOncologyPharmacology
2017English

Ubiquitin-Specific Peptidase 28 Enhances STAT3 Signaling and Promotes Cell Growth in Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Identification of a Novel Tumor Angiogenesis Inhibitor Targeting SHH/Gli1 Signaling Pathway in Non-Small Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy